Sheryl Freese
Family · Knoxville, TNNPI 1467765065
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $562 and has fallen 58.6% since, to $232 in 2024.
Across 73 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$150
- Johnson & Johnson$146
- Amgen$133
- Merck$102
- Novartis$92
- AstraZeneca$90
- plus $636 from 20 others
What the payments were for
- Food & beverage$1,33899%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $150 |
| Johnson & Johnson | 8 | $146 |
| Amgen | 6 | $133 |
| Merck | 4 | $102 |
| Novartis | 4 | $92 |
| AstraZeneca | 5 | $90 |
| Bayer | 4 | $73 |
| Genentech USA, Inc. | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| E.r. Squibb & Sons, L.L.C. | 3 | $47 |
| Seagen Inc. | 3 | $40 |
| Astellas Pharma US Inc | 2 | $39 |
| Puma Biotechnology, Inc. | 2 | $39 |
| Gilead(2 entities) | 2 | $34 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $33 |
| Karyopharm Therapeutics Inc. | 2 | $32 |
| Eisai Inc. | 2 | $27 |
| Bristol Myers Squibb | 1 | $18 |
| Pfizer | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Dova Pharmaceuticals | 1 | $16 |
| Secura Bio, Inc. | 2 | $16 |
| Sanofi | 1 | $16 |
| Incyte Corporation | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
How this compares
$1,350 in reported general payments places this provider in the 70th percentile of 6,706 family providers in Tennessee.
Other family in Knoxville
- Dana WebberKnoxville$499K
- Tiffany SipeKnoxville$87K
- Ashley BonnellKnoxville$49K
- Stacey MaltmanKnoxville$34K
- Katherine JohnsonKnoxville$32K
- Ashley BellKnoxville$22K
- Carol HawkinsKnoxville$22K
- Mina FarrarKnoxville$21K
- Amy AllenKnoxville$21K
- Sarah HarderKnoxville$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.